Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand
Hypersensitivity pneumonitis (HP) is an immune-mediated interstitial lung disease (ILD) relating to specific occupational, environmental or medication exposures. Disease behaviour is influenced by the nature of exposure and the host response, with varying degrees of lung inflammation and fibrosis seen within individuals. The differentiation of HP from other ILDs is important due to distinct causes, pathophysiology, prognosis and management implications. This Thoracic Society of Australia and New Zealand (TSANZ) position statement aims to provide an up-to-date summary of the evidence for clinicians relating to the diagnosis and management of HP in adults, in the Australian and New Zealand context. This document highlights recent relevant findings and gaps in the literature for which further research is required.
Authors
- Sandhya Limaye (ORCID: https://orcid.org/0000-0002-0528-1142)
- Tamera J. Corte (ORCID: https://orcid.org/0000-0002-5076-8929)
- John Harrington (ORCID: https://orcid.org/0000-0003-1542-6250)
- Hayley Barnes (ORCID: https://orcid.org/0000-0002-7615-4191)
- Peter T. Bell (ORCID: https://orcid.org/0000-0002-0653-0286)
- Gregory J. Keir (ORCID: https://orcid.org/0000-0001-9979-8726)
- Lauren Troy (ORCID: https://orcid.org/0000-0002-7426-336X)
- Leona Dowman (ORCID: https://orcid.org/0000-0001-8122-8063)
- Yet Hong Khor (ORCID: https://orcid.org/0000-0002-5434-9342)
- Lutz Beckert (ORCID: https://orcid.org/0000-0002-2688-9325)
- Jérémy Wrobel (ORCID: https://orcid.org/0000-0001-5165-2138)
- Rebekah De Losa (ORCID: https://orcid.org/0000-0001-7080-8572)
- Pradeep Balakrishnan (ORCID: https://orcid.org/0000-0001-5720-052X)
- Wendy A. Cooper (ORCID: https://orcid.org/0000-0001-5418-4229)
- David Milne (ORCID: https://orcid.org/0000-0002-3696-2805)
- Elizabeth Veitch (ORCID: https://orcid.org/0009-0002-3449-649X)
Institutions
- The University of Sydney (AU)
- The University of Queensland (AU)
- The University of Melbourne (AU)
- The University of Western Australia (AU)
- Lincoln University (NZ)
- Royal Prince Alfred Hospital (AU)
- Concord Repatriation General Hospital (AU)
- John Hunter Hospital (AU)
- Fiona Stanley Hospital (AU)
- Princess Alexandra Hospital (AU)
- The Alfred Hospital (AU)
- Northern Hospital (AU)
- Hunter Medical Research Institute (AU)
- Cooperative Trials Group for Neuro-Oncology (AU)
- Institute for Breathing and Sleep (AU)
- Sunshine Coast University Hospital (AU)
- St John of God Hospital (AU)
- Austin Health (AU)
- National Health and Medical Research Council (AU)
- Monash University (AU)
- Western Sydney University (AU)
- University of Otago (NZ)
- The University of Notre Dame Australia (AU)
- Macquarie University (AU)
Publication Details
- Journal
- Respirology
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1111/resp.14847
- Citations
- 7
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 2.93
Funders
- Bristol-Myers Squibb
- United Therapeutics Corporation
- Thoracic Society of Australia and New Zealand